Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer

Storebjerg, TM; Strand, SH; Hoyer, S; Lynnerup, AS; Borre, M; Orntoft, TF; Sorensen, KD

Sorensen, KD (reprint author), Aarhus Univ Hosp, Dept Mol Med, Aarhus, Denmark.

CLINICAL EPIGENETICS, 2018; 10 ():

Abstract

Background: Prognostic tools for prostate cancer (PC) are inadequate and new molecular biomarkers may improve risk stratification. The epigenetic mark......

Full Text Link